Document is current
Any future updates will be listed below
-
Authors
Hirose, Masaki
Arai, Toru
Sugimoto, Chikatoshi
Takimoto, Takayuki
Sugawara, Reiko
Minomo, Shojiro
Shintani, Sayoko
Takeuchi, Naoko
Katayama, Kanako
Inoue, Yasushi
Kagawa, Tomoko
Kasai, Takahiko
Akira, Masanori
Inoue, Yoshikazu https://orcid.org/0000-0003-3994-874X
-
Funding
Funding for this research was provided by:
Japan Society for the Promotion of Science (15K09203)
Japan Agency for Medical Research and Development (JP19ek0109268)
Ministry of Health, Labour and Welfare (H29-023)
- License Information
-
More Information
Article History
Received: 16 November 2020
Accepted: 18 February 2021
First Online: 2 March 2021
Declarations
:
: We obtained written informed consent from all subjects prior to prospective assignment to the cohort, data collection, and serum collection (approval number: 365). The present study was also approved by the institutional review board of the Kinki-Chuo Chest Medical Centre, Sakai City, Osaka, Japan (approval number: 576).
: All subjects of this study provided written informed consent for the publication of the present findings.
: YI is a member of the advisory board of SAVARA and steering committee of Boehringer Ingelheim regarding in this study. There are no other conflicts of interest to report.
